Affordable Access

deepdyve-link
Publisher Website

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types.

Authors
  • Kavanagh, K
  • Pollock, K G J
  • Potts, A
  • Love, J
  • Cuschieri, K
  • Cubie, H
  • Robertson, C
  • Donaghy, M
Type
Published Article
Journal
British Journal of Cancer
Publisher
Springer Nature
Publication Date
May 27, 2014
Volume
110
Issue
11
Pages
2804–2811
Identifiers
DOI: 10.1038/bjc.2014.198
PMID: 24736582
Source
Medline
License
Unknown

Abstract

This data demonstrate the positive impact of bivalent vaccination on the prevalence of HPV 16, 18, 31, 33 and 45 in the target population and is encouraging for countries which have achieved high-vaccine uptake.

Report this publication

Statistics

Seen <100 times